• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarey Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3360.0
  • ISIN : INE198H01019
107.72 -2 (-1.52%)
  • As on 07 Nov 2026 (EOD)

  • Today’s Low

    105.15

  • Today’s High

    108.57

  • Open

    105.15

  • Perv Close

    109.38

  • 52W Low

    50.31

  • 52W High

    114.80

Key Indicators

  • P/E(TTM)

    82.67

  • Mar.Cap (₹Cr.)

    343.35

  • Div & Yield %

    0.00

  • Book Value(₹)

    53.28

  • Debt-Equity Ratio

    -1.52

  • AGM Date

    06-Nov-2026

  • EPS

    1.31

  • P/E Ratio

    82.67

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    343.35

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    31.87

  • BV (₹)

    53.30

  • Sales( ₹ in Cr.)

    472.27

  • NP (in Cr.)

    3.97

  • NP Var(%)

    -1.0

  • Div%

    0.0

  • CPS (₹)

    2.10

  • EPS (₹)

    1.20

  • Traded Value (₹ in Lakhs)

    345.20

  • 52 Week High

    114.80

  • 52 Week Low

    50.31

  • Price BSE

    108.0

  • Price NSE

    108.00

  • Market Capital( in Cr.)

    345.20

  • P/C Ratio

    50.50

  • P/E Ratio

    86.80

  • Price Vs.BV

    1.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 472.27 473.94 395.62 418.96 492.76 348.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 472.27 473.94 395.62 418.96 492.76 348.42
Other Income 6.10 9.81 6.96 2.73 2.67 7.01
Stock Adjustments -3.94 10.80 5.86 15.14 -4.77 1.46
Total Income 474.43 494.55 408.44 436.83 490.66 356.89
EXPENDITURE :            
Raw Materials 450.56 472.87 387.76 418.98 461.35 335.96
Power and Fuel Cost 0.02 0.05 0.03 0.03 0.04 0.00
Employee Cost 0.56 0.62 0.54 0.63 0.67 0.20
Other Manufacturing Expenses 1.27 1.96 0.76 1.50 7.15 4.99
Selling and Administration Expenses 8.42 6.22 7.68 4.52 6.89 3.88
Miscellaneous Expenses 0.32 0.13 0.26 0.71 0.50 0.20
Employee Benefit Expenses 0.56 0.62 0.54 0.63 0.67 0.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 461.15 481.85 397.03 426.37 476.60 345.23
Operating Profit 13.27 12.71 11.42 10.45 14.07 11.66
Interest 5.00 4.66 4.38 2.87 2.04 2.44
Gross Profit 8.27 8.05 7.04 7.58 12.03 9.22
Depreciation 2.85 1.94 1.70 1.57 1.99 0.92
Profit Before Tax 5.42 6.11 5.34 6.01 10.04 8.30
Current Tax 1.59 1.91 1.33 2.28 3.59 1.66
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.15 0.17 -0.67 -0.04 -0.11 0.12
Reported Net Profit 3.97 4.02 4.68 3.77 6.55 6.51
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.97 4.02 4.68 3.77 6.55 6.51
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -0.01 0.00
P & L Balance brought forward 57.13 53.11 48.42 44.65 38.11 31.59
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 61.10 57.13 53.11 48.42 44.65 38.11
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.39 1.41 1.67 1.49 2.58 2.79
Earnings Per Share(Adj)-Unit Curr 1.39 1.41 1.67 1.49 2.58 2.79
Book Value 51.54 47.78 45.57 44.43 43.85 41.29
Book Value(Adj)-Unit Curr 51.54 47.78 45.57 44.43 43.85 41.29

Shareholding Pattern

  • Promoter Group

    41.45%

  • Public Share Holding

    58.55%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,010,000 6.31 2,010,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,202,443 35.15 11,202,443 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,212,443 41.45 13,212,443 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,362,317 4.27 1,362,317 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 459,667 1.44 459,667 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,821,984 5.72 1,821,984 5
2] Non Institution
Bodies Corporate 2,887,894 9.06 2,866,414 86
Clearing Members 336,526 1.06 336,526 13
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 99,338 0.31 99,338 79
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 523,560 1.64 523,560 184
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,405,796 26.37 7,405,796 100
Individuals holding nominal share capital up to Rs. 1 lakh 4,407,641 13.83 3,919,042 13,002
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,839,876 52.83 15,329,797 13,472
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 31,874,303 100.00 30,364,224 13,485

Company Background

Aarey Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarey Drugs & Pharmaceuticals Ltd
  • BSE Code : 3360.0
  • ISIN : INE198H01019

  • Incorporation Year

    1990

  • Registered Office

    E-34 MIDC Tarapur
    Boisar, Thane,
    Maharashtra-401506

  • Telephone

    91-22-23455543

  • FAX

  • Chairman

    Mihir R Ghatalia

  • Managing Director

    Mihir R Ghatalia

  • Company Secretary

    KAILASH CHAND JETHLIA

  • Auditor

    Motilal & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarey Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarey Drugs 108.30 478.37 472.27 82.67 5.58
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77